CMS

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors

Retrieved on: 
Thursday, February 29, 2024

Key findings include that TriNav patients, despite a higher baseline disease burden and clinical complexity, showed overall clinical results comparable to patients with lower disease burden.

Key Points: 
  • Key findings include that TriNav patients, despite a higher baseline disease burden and clinical complexity, showed overall clinical results comparable to patients with lower disease burden.
  • In a matched cohort comparison, TriNav patients had fewer 30-day inpatient visits post-procedure than non-TriNav patients.
  • TriNav TARE patients with liver metastases had fewer clinical complications post-procedure vs. non-TriNav patients in a matched cohort comparison.
  • “This large sample size study underscores the particular benefits of the TriNav device compared to standard drug delivery systems.”

Acquia Announces 2023 Partner Award Winners

Retrieved on: 
Thursday, February 29, 2024

Acquia , the digital experience leader, today announced the winners of the 2023 Partner Awards, which showcase the top performers in Acquia’s partner ecosystem.

Key Points: 
  • Acquia , the digital experience leader, today announced the winners of the 2023 Partner Awards, which showcase the top performers in Acquia’s partner ecosystem.
  • The company recognized 24 organizations globally based on superior customer outcomes, innovative work with the open source Drupal content management system (CMS) and the Acquia digital experience platform ( Acquia DXP ), and revenue performance.
  • “Each of our 2023 winners went above and beyond to deliver value to customers and enable the creation of game-changing, productive digital experiences,” said Darren Burris, VP of Channels at Acquia.
  • Learn more and find an Acquia partner at https://www.acquia.com/partners .

Gradial Raises $5.4 million Seed Financing for Generative AI Solution for Content Management and Marketing Operations

Retrieved on: 
Wednesday, February 28, 2024

Gradial is building AI solutions to help marketing teams deliver better digital experiences and enable more time and resources for creative strategy.

Key Points: 
  • Gradial is building AI solutions to help marketing teams deliver better digital experiences and enable more time and resources for creative strategy.
  • Gradial streamlines routine marketing workflows using AI automation that integrates with legacy systems to speed content management lifecycles and deliver customer insights.
  • Marketing tools like a content management system (CMS) are critical content repositories of copy, imagery, and design for brands, but can grow bulky and hard to maintain over time.
  • Using generative image and text models and a native integration with the CMS, Gradial addresses common content management pain points for global brands such as making content updates, redesigning web pages, and creating brand-aligned content.

Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada

Retrieved on: 
Wednesday, February 28, 2024

(NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the Canadian Intellectual Property Office for its patent application titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.

Key Points: 
  • (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the Canadian Intellectual Property Office for its patent application titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.
  • This invention addresses the use of Namodenoson for the reduction of liver fat in patients with NASH a clinical indication that is being developed by Can-Fite.
  • The Company also has a distribution agreement in Canada for its anti-inflammatory drug, Piclidenoson, for the treatment of psoriasis.
  • “This additional patent in Canada for fatty liver disease adds to our growing IP estate for this high-value indication of the Namodenoson drug candidate.

Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update

Retrieved on: 
Wednesday, February 28, 2024

Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.
  • Excluding depreciation, amortization, stock-based compensation and restructuring charges, non-GAAP R&D expenses were $18.6 million and $65.5 million, respectively, for the fourth quarter and full year ended December 31, 2023.
  • Fourth quarter and full year 2023 RHA Collection revenue of $34.5 million and $128.6 million, respectively.
  • ET on February 28, 2024, to discuss its financial results and provide a corporate update.

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer

Retrieved on: 
Monday, February 26, 2024

These determinations add to a growing list of covered indications for Signatera, including adjuvant and recurrence monitoring coverage in colorectal cancer, muscle-invasive bladder cancer, and breast cancer; and pan-cancer immunotherapy response monitoring.

Key Points: 
  • These determinations add to a growing list of covered indications for Signatera, including adjuvant and recurrence monitoring coverage in colorectal cancer, muscle-invasive bladder cancer, and breast cancer; and pan-cancer immunotherapy response monitoring.
  • The MolDX coverage decision applies to patients with ovarian cancer, in both the adjuvant and surveillance settings.
  • This MolDx coverage decision applies to patients with breast cancer in the neoadjuvant setting across all subtypes of the disease, including hormone receptor (HR)-positive, HER2-positive, and triple negative breast cancers.
  • We are incredibly proud of this milestone, and look forward to continuing to work with Medicare to make Signatera more widely accessible for people affected by cancer.”

PointClickCare Sets Industry Standard in Long-Term and Post-Acute Care (LTPAC) with New ONC Health IT Certification

Retrieved on: 
Monday, February 26, 2024

This certification reinforces the company’s commitment to patient safety, improving health outcomes and reducing the cost of care – the core tenets of Value-Based Care (VBC).

Key Points: 
  • This certification reinforces the company’s commitment to patient safety, improving health outcomes and reducing the cost of care – the core tenets of Value-Based Care (VBC).
  • The ONC Health IT Certification Program is a pivotal initiative that validates health IT products' compliance with federal standards and criteria set by the Department of Health and Human Services (HHS).
  • “PointClickCare's ONC CEHRT designation signifies a commitment to LTPAC providers that we’re invested in their success, inclusive of any value-based reimbursement models they’re participating in,” said B.J.
  • To learn more about this industry recognition, and how it serves as a mark of quality and reliability in the health IT market, visit our website here .

Humana Announces Strategic Partnership with Veda to Improve Accuracy of Provider Directories

Retrieved on: 
Monday, February 26, 2024

Leading health and well-being company Humana Inc. (NYSE: HUM) today announced a strategic partnership with Veda , a health technology company specializing in helping healthcare companies solve complex provider data challenges.

Key Points: 
  • Leading health and well-being company Humana Inc. (NYSE: HUM) today announced a strategic partnership with Veda , a health technology company specializing in helping healthcare companies solve complex provider data challenges.
  • Humana will partner with Veda to improve the accuracy of its provider information and ensure that seniors have real-time details about in-network providers, making it easier for them to access high-quality healthcare.
  • Ensuring the accuracy of provider directories has been the source of ongoing challenges for seniors, health plans, providers and policymakers.
  • “We want to be a partner with CMS and policymakers in improving the accuracy of provider directories.

Now Media Deploys on Base to Build the Future of Authenticated Media

Retrieved on: 
Monday, February 26, 2024

Today, Now Media announced that it deployed on Base, an Ethereum L2 incubated by Coinbase, to advance the adoption of authenticated media as the industry standard for digital publishers.

Key Points: 
  • Today, Now Media announced that it deployed on Base, an Ethereum L2 incubated by Coinbase, to advance the adoption of authenticated media as the industry standard for digital publishers.
  • "With Sovereignty®, we are building KYC for digital publishers," said Alejandro Navia, Co-Founder and President of Now Media.
  • Base is the perfect platform for Now Media to build Sovereignty® and make authenticated media a new industry standard.
  • Now Media is the first media company to tokenize their content in this way and through this deployment with Base, they will expand to authenticate media for industry-leading publications to combat misinformation.

AirHop Joins Ericsson Intelligent Automation Platform Ecosystem

Retrieved on: 
Friday, February 23, 2024

AirHop Communications , a provider of AI-powered automation and optimization solutions for 4G and 5G Radio Access Networks (RAN), today announced they have joined the Ericsson Intelligent Automation Platform (EIAP) Ecosystem.

Key Points: 
  • AirHop Communications , a provider of AI-powered automation and optimization solutions for 4G and 5G Radio Access Networks (RAN), today announced they have joined the Ericsson Intelligent Automation Platform (EIAP) Ecosystem.
  • The collaboration enables the integration of AirHop’s AI-powered RAN automation and optimization Auptim rApps with Ericsson’s Service Management and Orchestration (SMO) and non-Real-Time RAN Intelligent Controller (RIC).
  • AirHop's AI-powered intelligent automation and optimization technology has been successfully deployed and enhanced in some of the world's largest and most innovative CSP networks.
  • AirHop has established a broad Open RAN ecosystem that includes HPE, IBM, Juniper, Rakuten Symphony and VMware, which is now extended with AirHop's membership of the EIAP Ecosystem.